Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.75 USD
Change Today +0.005 / 0.18%
Volume 2.2M
OREX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Stuttgart
As of 8:10 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - orexigen therapeutics inc (OREX)

NameBoard RelationshipsTitleAge
Michael A. Narachi M.S., M.B.A.21 RelationshipsChief Executive Officer, President and Director56
Michael A. Cowley Ph.D.4 RelationshipsCo-Founder46
Joseph P. Hagan 11 RelationshipsChief Business & Financial Officer and Treasurer46
Thomas R. Cannell DVMNo RelationshipsChief Commercial Officer and Executive Vice President53
Preston S. Klassen M.D., M.H.S.11 RelationshipsHead of Global Development and Executive Vice President46

Board Members - orexigen therapeutics inc (OREX)

NameBoard RelationshipsPrimary CompanyAge
Eckard Weber M.D.77 RelationshipsOcera Therapeutics, Inc.65
Michael A. Narachi M.S., M.B.A.21 RelationshipsOrexigen Therapeutics, Inc.56
Brian H. Dovey 73 RelationshipsDomain Associates, L.L.C.73
Patrick J. Mahaffy MA24 RelationshipsClovis Oncology, Inc.52
Peter K. Honig M.D., MPH16 RelationshipsOrexigen Therapeutics, Inc.58

Executive Committees* - orexigen therapeutics inc (OREX)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeLota S. Zoth CPA 40 Relationships2 Executives
Compensation CommitteeBrian H. Dovey 73 Relationships3 Executives
Nominating CommitteePatrick J. Mahaffy MA 24 Relationships1 Executives
Corporate Governance CommitteePatrick J. Mahaffy MA 24 Relationships1 Executives
View OREX Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OREX:US $2.75 USD +0.005

OREX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arena Pharmaceuticals Inc $2.75 USD +0.05
GlaxoSmithKline PLC 1,311 GBp -27.50
Novo Nordisk A/S kr366.30 DKK -7.10
VIVUS Inc $1.26 USD +0.02
View Industry Companies
 

Industry Analysis

OREX

Industry Average

Valuation OREX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.4x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OREXIGEN THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.